Walter J. Curran

Hyperfractionated radiation therapy and bis-chlorethyl nitrosourea in the treatment of malignant glioma—Possible advantage observed at 72.0 Gy in 1.2 Gy B.I.D. fractions: Report of the radiation therapy oncology group protocol 8302

Diana F. Nelson, Walter J. Curran, Charles Scott et al. · International Journal of Radiation Oncology*Biology*Physics · 1993 · 160 citations

Radiation Medicine, Radiation Therapy, Medicine +10

Elapsed treatment days—A critical item for radiotherapy quality control review in head and neck trials: RTOG report

Thomas F. Pajak, George E. Laramore, Víctor A. Marcial et al. · International Journal of Radiation Oncology*Biology*Physics · 1991 · 155 citations

Rtog Report, Radiation Medicine, Radiation Therapy +10

Does extent of surgery influence outcome for astrocytoma with atypical or anaplastic foci (AAF)? A report from three Radiation Therapy Oncology Group (RTOG) trials

Walter J. Curran, Charles Scott, John Horton et al. · Journal of Neuro-Oncology · 1992 · 111 citations

Neuro-oncology, Surgical Oncology, Radiation Therapy +10

Technique, pharmacokinetics, toxicity, and efficacy of intratumoral etanidazole and radiotherapy for treatment spontaneous feline oral squamous cell carcinoma

Sydney M. Evans, Frank LaCreta, Stuart C. Helfand et al. · International Journal of Radiation Oncology*Biology*Physics · 1991 · 39 citations

Oncology, Intratumoral Etanidazole, Radiation Therapy +6

Comparison of the radiation therapy oncology group and american joint committee on cancer staging systems among patients with non-small cell lung cancer receiving hyperfractionated radiation therapy. A report of the radiation therapy oncology group protocol 83-11

Walter J. Curran, Robert E. Krisch, James D. Cox et al. · Cancer · 1991 · 23 citations · Full text

Adaptive Radiotherapy, Advanced Nsclc, Radiation Medicine +14